SCHEMBL13435569

SCHEMBL13435569

Cc1cc(=O)c2ccc3ccccc3c2o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 7/20 0.62
CYP1B1 Q16678 7/20 0.62
CYP1A2 P05177 6/20 0.62
KDM4E B2RXH2 5/20 0.62
ALDH1A1 P00352 5/20 0.62
HPGD P15428 4/20 0.62
MAPT P10636 4/20 0.62
HTT P42858 4/20 0.62
PRKDC P78527 3/20 0.62
HSD17B10 Q99714 2/20 0.62
CYP3A4 P08684 2/20 0.62
TSHR P16473 2/20 0.62
CYP2C19 P33261 2/20 0.62
ALOX15 P16050 1/20 0.62
PDE5A O76074 1/20 0.62
TP53 P04637 1/20 0.62
ABCB1 P08183 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP19A1 P11511 1/20 0.62
CYP2C9 P11712 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30009780 0.80 KMT2A (0.51) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL25655884 0.80 KMT2A (0.51) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL3607241 0.79 PRKDC (0.64) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL16736777 0.79 PRKDC (0.73) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL20594586 0.79 CYP1A1 (0.78) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL29407618 0.79 CYP1A1 (0.78) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
Alpha-Naphthoflavone SCHEMBL29351090 0.77 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL12325500 0.77 KDM4E (0.63) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
Alpha-Naphthoflavone SCHEMBL121594 0.77 CYP1A1 (1.00) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1
SCHEMBL1319784 0.77 PRKDC (0.55) CYP1A1CYP1B1CYP1A2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994079-A Method for synthesizing chromone, 1-thiochromone and gamma-pyrone compounds 中国科学院上海药物研究所 2024-11-22 CN disclosed
US-7674823-B2 DNA-PK inhibitors CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2010-03-09 US disclosed
US-20070238729-A1 DNA-PK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-10-11 US disclosed
US-7226918-B2 DNA-PK inhibitors CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2007-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238729-A1 DNA-PK INHIBITORS ATM, CHEK2, CHEK1 CYP1A1 1196/4885CYP1B1 1027/4885CYP1A2 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.